IN VIVO is the premier resource for life science business strategy, providing in-depth analysis of the biopharma, medtech, and diagnostics industries in one package. Every month it delivers unparalleled deals analysis, interesting narratives, insider interviews, and think pieces to help readers make sense of the rapidly changing health care environment.
IN VIVO strives to unveil the “so what” underpinning current industry events in clear, precise language so that readers can make proactive rather than reactive business decisions. This knowledge helps companies broker deals with confidence and identify opportunities that competitors may miss. Unlike other business publications, IN VIVO delves into the complexities behind the headlines and sound bites, searching for meaning in the available data. The magazine’s award-winning analysts compile the information in an accessible format that outlines the implications for you and your company.
IN VIVO delivers:
- Revealing, in-depth coverage of your competitors’ strategies
- Incisive projections of future industry trends and their implications for your business
- Expert analysis of key industry developments
- Exclusive interviews with top industry executives and analysts
- Rich deals data from around the world
- In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies — those that were successful and those that missed the mark
Your IN VIVO free trial will include:
- Email updates: Twice-weekly updates delivered to your inbox
- Topical RSS Feeds